The Effects of Nifedipine and Other Calcium Antagonists on the Glibenclamide-sensitive K+ Currents in Smooth Muscle Cells from Pig Urethra
Overview
Authors
Affiliations
1. The effects of nifedipine on both levcromakalim-induced membrane currents and unitary currents in pig proximal urethra were investigated by use of patch-clamp techniques (conventional whole-cell configuration and cell-attached patches). 2. Nifedipine had a voltage-dependent inhibitory effect on voltage-dependent Ba2+ currents at - 50 mV (Ki=30.6 nM). 3. In current-clamp mode, subsequent application of higher concentrations of nifedipine (> or =30 microM) caused a significant depolarization even after the membrane potential had been hyperpolarized to approximately -82 mV by application of 100 microM levcromakalim. 4. The 100 microM levcromakalim-induced inward current (symmetrical 140 mM K+ conditions, -50 mV) was inhibited by additional application of three different types of Ca antagonists (nifedipine, verapamil and diltiazem, all at 100 microM). In contrast, Bay K 8644 (1 microM) possessed no activating effect on the amplitude of this glibenclamide-sensitive current. 5. When 100 microM nifedipine was included in the pipette solution during conventional whole-cell recording at -50 mV, application of levcromakalim (100 microM) caused a significant inward membrane current which was suppressed by 5 microM glibenclamide. On the other hand, inclusion of 5 microM glibenclamide in the pipette solution prevented levcromakalim from inducing an inward membrane current. 6. The levcromakalim-induced K+ channel openings in cell-attached configuration were suppressed by subsequent application of 5 microM glibenclamide but not of 100 microM nifedipine. 7. These results suggest that in pig proximal urethra, nifedipine inhibits the glibenclamide-sensitive 43 pS K+ channel activity mainly through extracellular blocking actions on the K+ channel itself.
Kyle B, Bradley E, Ohya S, Sergeant G, McHale N, Thornbury K Am J Physiol Cell Physiol. 2011; 301(5):C1186-200.
PMID: 21813710 PMC: 3213918. DOI: 10.1152/ajpcell.00455.2010.
London F, Marcinkiewicz M, Walsh P Biochemistry. 2006; 45(23):7289-98.
PMID: 16752917 PMC: 2533735. DOI: 10.1021/bi060294m.
Teramoto N, Tomoda T, Ito Y Br J Pharmacol. 2005; 144(7):919-25.
PMID: 15723098 PMC: 1576071. DOI: 10.1038/sj.bjp.0706051.
Hatano N, Ohya S, Muraki K, Giles W, Imaizumi Y Br J Pharmacol. 2003; 139(3):533-44.
PMID: 12788813 PMC: 1573880. DOI: 10.1038/sj.bjp.0705281.
Roberts R Br J Pharmacol. 2003; 138(1):107-16.
PMID: 12522079 PMC: 1573640. DOI: 10.1038/sj.bjp.0705014.